Overview
Low Dose Fluorescein Angiography Comparing 1mL and 3mL of 10% Fluorescein
Status:
Not yet recruiting
Not yet recruiting
Trial end date:
2024-01-31
2024-01-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
This study aims to compare the efficacy and safety of fluorescein angiography using 1mL versus 3mL of 10% fluorescein dye.Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Seoul National University Bundang Hospital
Criteria
Inclusion Criteria:- Patients who required an fluorescein angiography for their retinal diseases (eg.
diabetic retinopathy, retinal vein occlusion, etc.)
Exclusion Criteria:
- media opacity (corneal opacity, vitreous hemorrhage grade 2 or more, cataract LOCS III
grade 3 or more)
- known history of adverse reactions to fluorescein
- dilated pupil diameter less than 5 mm